Fumarate Hydratase Deficiency

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-04-09
Clinical Trial Update: Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating sintilimab in combination with Inlyta for fumarate hydratase-deficient renal cell carcinoma is currently active but…